Welcome to Crene Biotechnology!

+86-576-88205808

Catalog No CAS NO Product name
CR1256
677297-51-7
TG100-115
TG100-115, inhibited PI3K γ and -δ(IC50 values of 83 and 235 nM, respectively), whereas both PI3Kα and -β were relatively unaf..
CR1234
944396-07-0
BKM120 Buparlisib
Buparlisib, also known as BKM120, is an orally bioavailable specific oral inhibitor of the pan-class I phosphatidylinositol 3-kina..
CR1226
1086062-66-9
GSK2126458 Omipalisib
Omipalisib, also known as GSK2126458, is a small-molecule pyridylsulfonamide inhibitor of phosphatidylinositol 3-kinase (PI3K) wit..
CR1211
677338-12-4
PIK-90
PIK-90 is a potent PI3K inhibitor with potential anticancer activity.PIK-90 shows distinct patterns of isoform selectivity to inhi..
CR1192
956958-53-5
XL147 PI3K inhibitor X
XL147-II is an ATP-competitive inhibitor of class I PI3K isoforms. It acts by abrogating Akt and S6 phosphorylation in HER2+ cells..
CR1187
957054-33-0
Pictilisib mesylate
Pictilisib, also known as Pictrelisib, GDC-0941, RG7321 and GNE0941 , is an orally bioavailable, and is a potent small-molecule th..
CR1186
957054-30-7
GDC-0941 Pictilisib
Pictilisib, also known as Pictrelisib, GDC-0941, RG7321 and GNE0941 , is an orally bioavailable, and is a potent small-molecule th..
CR1155
371242-69-2
IC-87114
IC-87114 (IC87114), an analog of the original inhibitor, is synthesized and tested for PI3Kδ selectivity relative to the other cl..
CR1058
913358-93-7
Almorexant HCL
Almorexant Hcl (ACT078573) is a potent and competitive dual orexin 1 receptor (OX1)/orexin 2 receptor (OX2) antagonist with Ki val..
CR1057
870281-82-6
Idelalisib (CAL-101)
CAL-101 is a highly selective and potent p110δ inhibitor with IC50 of 2.5 nM, is 40- to 300-fold more selective for p110..
首页上一页当前第3/4页共31条记录每页10条1234下一页尾页
Products are chemical reagents for research use only and are not intended for human use. We do not sell to patients.
Friendly link:

Copyright Copyright (C) 2018-2021 Taizhou Crene Biotechnology Co.,Ltd.  

Address:Economic Developed Zone of Taizhou Zhejiang China